Screener
Medline, Inc. MDLN Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
| (in millions) | Six months ended / June 27, 2026 | Six months ended / June 28, 2025 |
|---|---|---|
| Stock-based compensation expense | 52 | 34 |
| Amortization of deferred financing costs | 24 | 30 |
| Deferred taxes | 101 | (7) |
| Credit losses | 7 | 39 |
| Unrealized foreign exchange (gain) loss, net | (17) | 94 |
| Loss on extinguishment of debt | 23 | — |
| Non-cash lease expense | 35 | 35 |
| Fire at distribution center | 320 | — |
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s accounts receivable, credit loss expense (reversal)?
- Medline, Inc. (MDLN) reported accounts receivable, credit loss expense (reversal) of $6M in Q2 2026.
- How has Medline, Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?
- Medline, Inc.'s accounts receivable, credit loss expense (reversal) decreased by 53.8% year-over-year, from $13M to $6M.
- What does accounts receivable, credit loss expense (reversal) mean?
- Accounts Receivable, Credit Loss Expense (Reversal)
Ask your AI about Medline, Inc.'s accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude